Biopharmaceutical companies spent an estimated $985 million on new drug development and research over a decade, counting expenditures on failed trials, according to researchers from the London School...
Tying drug prices to those in other developed countries may be a useful strategy for lowering US prescription drug spending, but international reference pricing may not be ideal, according to...
The city of Marietta has filed a class action lawsuit against drug manufacturer Mallinckrodt, claiming the company increased the price for a specific seizure medication by 97,500 percent, according to...
According to a GoodRx analysis, Myalept is the most expensive prescription drug in the US in 2020 with a list price of $72,306.
In their yearly analysis, GoodRx researchers broke down the most...
A new Congressional Research Service report on Wednesday delved into the deluge of proposals that have been set forth to address drug pricing and drug patenting practices.
The report is a high-level...
Drug prices increased for 686 drug products during the first few weeks of 2020, the latest data from the Centers for Medicare and Medicaid Services shows, signaling it’s business as usual for...
